Ex-100 Reporting Season Playbook

By Josephine (Jo) Little

28 July 2020, 1:00 PM

The quality of performance this period will likely be distorted by COVID-19 impacts and new accounting standards (ie. AASB16). We identify 20 stocks that we believe will likely have positive share price reactions to their results, six that will have negative reactions, and the remainder neutral.


COVID-19: Pathway to a vaccine

By Derek Jellinek

23 July 2020, 2:50 PM

Executives from five drug companies leading the COVID-19 vaccine race (ie AstraZeneca (LON; AZN), Johnson & Johnson (NYSE: JNJ), Merck (NYSE: MRK), Moderna (NASDAQ: MRNA), and Pfizer (NYSE: PFE)) appeared in front of the US House Energy and Commerce Oversight and Investigations Subcommittee to talk about their progress in developing a product the entire world desperately needs.

Results 21-30 of 500
  • Print this page
  • Copy Link